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Binding of the labeled anticonvulsant drug PH]dibenzocycloalkenimine (PH]MK-801) to the A’-methyl-D-aspartate 
(NMDA) receptor and its dissociation from the receptor at 25°C are slow processes, both of which follow first order 
kinetics (t112 u 70 and 180 min, respectively). Both reactions are markedly accelerated by glutamate and glycine (tljz= 5 -8 
and 4 min, respectively), which allow bimolecular association kinetics of the labeled drug with the receptors whereas equi- 
librium binding of PH]MK-801 (& 2-4 nM) is hardly affected by glutamate and glycine. The data suggest hat MK-801 
acts as a steric blocker of the NMDA receptor channel. The competitive antagonist D-( -)-2-amino-5-phosphovaleric 
acid (AP-5) freezes the receptor in a state which precludes either binding of PH]MK-801 to the receptor channel or its 
dissociation from it. These findings have therapeutic implications. 
Phencyclidine; NMDA receptor; Dibenzocycloalkenimine 
1. INTRODUCTION 
PCP and related drugs, including the anticon- 
vulsant MK-801, are potent noncompetitive 
blockers of glutamate receptors of the NMDA sub- 
type [ 1,2]. Several authors have demonstrated a 
glutamate-induced enhancement of the binding of 
[3H]MK-801 as well as of t3H]TCP, a potent PCP 
analog [2-51. We recently showed that the en- 
hanced binding of [‘H]TCP is due not to a change 
in the equilibrium binding but rather to an ac- 
celeration in the rates of both association and 
dissociation of the receptor-ligand complex [5]. 
The mechanism of interaction between [3H]MK- 
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801 and the NMDA receptor is however not 
known. In this paper we describe kinetic and 
equilibrium binding experiments with J3H]MK- 
801, which point to a nonallosteric interaction be- 
tween NMDA receptor against binding sites and 
the [3H]MK-801 binding site. 
2. MATERIALS AND METHODS 
[3H]MK-801 (29.4 Ci/mmol) was purchased from New 
England Nuclear. All other chemicals were as detailed [5]. 
Binding assays were performed in triplicate at 25°C with 
repeatedly washed rat cerebra1 cortex membranes (8Opg pro- 
tein) as described elsewhere [5]. Assays were carried out in the 
absence or in the presence of low4 M AP-5, or in the presence 
of lO/rM MgClz together with 1 FM L-glutamate and 1 pM 
glycine. Nonspecific binding was determined in samples con- 
taming 1O-4 M PCP. Data were expressed as the specific bin- 
ding of [‘H]MK-801 and analyzed according to the two-step 
binding mode1 of interactions between oncompetitive blockers 
and the NMDA receptor channel [5]. The model assumes a first 
order diffusion of the ligand from the outside into the interior 
of the channel, followed by association of the ligand with its 
receptor sites. Under the two extreme conditions employed 
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here, viz.; binding of [3H]MK-801 in the presence of agonists 3. RESULTS AND DISCUSSION 
(unlimited iffusion) and in the absence of agonists (limited if- 
fusion) the time courses of receptor occupation should respec- 
tively follow pseudo-first order (eon 1) and first order (eqn 2) 
Fig.lA demonstrates typical time courses for 
kinetics [5]: [3H]MK-801-receptor association, with and 
([RLI,, - tRLI)/(lRLl,, = exp. - (klkZ[L]/kb - k-dt (1) 
without glutamate and glycine. The association 
1 - (&[RL]/[L]([&] - [RL] ) = eXp. - kbt (2) 
rate of 5 nM [3H]MK-801 with the receptor in the 
absence of exogenous agonists was very slow (fl/z 
where L, RT, RL,s and RL are respectively the ligand, the total 
number of binding sites, the bound ligand at equilibrium and at 
time f. k, and kb are the forward and backward diffusion con- 
stants; kl and k-1 are the second order on-rate and the first 
order off-rate constants for the binding process. The overall 
equilibrium binding constant (&) is given by k-1. kb/kl . kz. 
2: 70 min) and reached equilibrium only after a 
prolonged incubation time (>6 h). Upon addition 
of glutamate and glycine the rate of [‘HIMK-801 
binding to the receptor was markedly increased 
@l/2 1: 7 min) and the reaction approached 
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I I I I 
0 1 2 3 4 5 6 +% 
Time (hr) 
2 6 10 20 40 60 
[34 MK-801 (nM) Time (min) 
Fig. 1. (A) Time course of association of [3H]MK-801 (5 nM) with the NMDA receptor channel, Binding was determined at 25°C as 
a function of time in the absence (0) and in the presence of glutamate and glycine (0) or in the presence of AP-5 (A). (B) The 
observed time constants (&bS ) are derived from the pseudo-first order plots of the association of 2, 5 and 8.6 nM [3H]MK-801 in 
the presence of glutamate and glycine plotted as a function of the ligand concentration. (C) First order plot (eqn 2) of 
[‘H]MK-801-receptor association in the absence of agonists determined with Iigand concentrations of 2 nM (0) and 8.6 nM (e). 
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equilibrium within 45-60 min. The increase in 
ligand-receptor binding was time-dependent; im- 
mediately after the onset of binding it was very 
high (-9 times that of the control) and then it 
declined (fig.lA). Similar time courses (not shown) 
were followed by 2 nM and 8.6 nM [3H]MK-801. 
The kinetics of [3H]MK-801 binding in the 
presence of glutamate and glycine followed a 
pseudo-first order scheme (eqn 1): the observed 
time COnStantS (&bs) varied linearly with 
[3H]MK-801 concentrations (fig.lB), and the ratio 
between the apparent on-rate time constant (1.55 x 
10’ M-‘-min-‘) and the apparent off-rate time 
constant (0.075 min-‘) was 4.8 nM. This kinetical- 
ly derived dissociation constant (&) was similar to 
the Kd for [3H]MK-801 determined at equilibrium 
in the presence (4.2 nM) and in the absence 
(2.1 nM) of glutamate and glycine (fig.2). 
In the absence of exogenous agonists the kinetics 
of ligand-receptor association did not follow a 
pseudo-first order scheme, as shown by the fact 
that the half-times of the reactions (60-70 min) 
did not vary as a function of t3H]MK-801 concen- 
tration. These kinetics fitted well to the first order 
reaction scheme (eqn 2), and the observed time 
constant (kb) derived from the kinetics of ligand 
receptor association (2.28 x 10e3 min-‘, fig.lC) 
Equilibrium Bindine 
EH] MK-801 bound(pmol/mp prot.1 
was similar to the dissociation time constant ob- 
tained when receptor-ligand dissociation was 
measured in the absence of agonists (5.5 x 
10m3 min-‘, fig.2). Also, the addition of 1 /IM 
glutamate to [3H]MK-801-receptor complexes 
resulted in a marked increase in the dissociation 
rate (half-time 18 min, compared to the control 
value of 180 min, fig.2) and the effect was enhanc- 
ed by glycine (half-time 4 min, fig.2). Consistency 
with the two-step binding model (see section 2) was 
further shown by the fact that the dissociation rate 
constant determined in the presence of glutamate 
and glycine (0.1 min-‘, fig.2) was similar to k-1 
value obtained under the same conditions during 
ligand-receptor association (0.075 min-‘, fig.lB). 
Taken together, the association and dissociation 
kinetics of [3H]MK-801 binding to the receptor 
suggest hat in the absence of agonists the rate- 
limiting step is the diffusion of the outside ligand 
(L,) into the interior (L,) of the presumably closed 
NMDA receptor channel 
k 
Lcl + Lc, 
whereas in the presence of agonists this limitation 
is removed (presumably because the channel is 
c, olu*P~Y 
I I I I 
40 80 120 160 
Time (mini 
Fig.2. (Left) Equilibrium binding of [‘HIMK-801. Binding of [‘H]MK-801 as a function of its concentration was assayed after 
incubation for 4 h at 25°C in the absence (0) or in the presence (0) of glutamate and glycine. Also shown are data for [‘HIMK-801 
binding to the receptor measured after their incubation for 3 h followed by an additional 1 h of incubation in the presence of 100 PM 
AP-5 (A). Data are expressed in the form of Scatchard plot. (Right) First order plots of the dissociation of [3H]MK-801-receptor 
complexes. Samples were incubated at 25°C with 8 nM [‘HIMK-801 for 2 h. The dissociation reaction was initiated by the addition 
of 100 PM unlabeled PCP. Data show the dissociation reaction without added agonists (0) and in the presence of 1 /tM glutamate 
(A), 1 CM glutamate + 1 gM glycine (O), or lOO/tM AP-5 (A). Reactions were terminated either immediately (zero time) or at the 
indicated times. B,, amount of [‘H]MK-801 bound at zero time. B1, amount of [3H]MK-801 bound at time t. 
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open) and the rate-limiting step is the binding pro- the NMDA-receptor channel and not as an 
cess itself. allosteric effector. 
4 
R + Lc E RL. 1 
It should be noted, however, that the competitive 
NMDA-receptor antagonist, AP-5, by itself 
decreases the rates of [3H]MK-801-receptor 
association (fig. 1A) and dissociation (fig.2) as 
compared to the control level, possibly indicating 
the presence of residual glutamate (or glycine) in 
the membrane preparation. It seems that AP-5 
‘freezes’ the receptor in such a way that 
[3H]MK-801 is prevented from penetrating into the 
channel (see fig.lA) or dissociating from it (fig.2). 
Indeed, the addition of AP-5 to preequilibrated 
[3H]MK-801-receptor complexes did not alter the 
equilibrium binding (fig.2). 
The findings of this study have important 
therapeutic implications: the channel-ligand com- 
plexes formed following in vivo administration of 
MK-801 can be prevented from dissociating by a 
competitive antagonist (e.g. AP-5), which freezes 
the complex. 
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